A. Bourgoin

发表

White paper: an outlook on U.S. biosimilar competition.

A. Bourgoin, B. Nuskey, 2013, Drugs of today.

Pharmacokinetic and pharmacodynamic properties of a new biosimilar filgrastim TPI G-CSF in comparison to the marketed reference filgrastim Neupogen®: a double-blind, single-dose, two-period crossover trial

Sarfaraz K. Niazi, A. Bourgoin, 2015 .